Top Urothelial Cancer Drugs Companies

  1. Merck

  2. Bristol-Myers Squibb

  3. Novartis

  4. Roche

  5. AstraZeneca

*Disclaimer: Top companies sorted in no particular order

Urothelial Cancer Drugs Market Major Players

Urothelial Cancer Drugs - Competitive Concentration

Urothelial Cancer Drugs Market Concentration

List of Urothelial Cancer Drugs Companies

  • Merck

  • Roche

  • Bristol-Myers Squibb

  • AstraZeneca

  • Novartis

  • GlaxoSmithKline

  • Sanofi

  • Eisai

  • Astellas Pharma

  • UroGen Pharma Ltd.

  • Pfizer

  • Seagen

  • Johnson & Johnson (Janssen Biotech)

  • Gilead Sciences

  • ImmunityBio Inc.

  • CG Oncology

  • QED Therapeutics Inc.

  • BeiGene Ltd.

  • Mirati Therapeutics Inc.

Get more insights on Urothelial Cancer Drugs industry from our comprehensive report